Read more
The renewal of interest in peritoneal dialysis as a treatment modality for patients with end-stage renal disease was stimulated by the report of Po povich and his colleagues in 1976 on the technique of CAPD. With the in troduction of commercial dialysate-containing plastic bags, which mark edly reduced the incidence of peritonitis, the use of CAPD as a primary treatment modality has increased significantly. At the present time, more than 12% of the patients undergoing dialysis in the United States are utiliz ing CAPD; however, the use of CAPD among pediatric patients is con siderably greater. The First International Symposium on CAPD in Children was orga nized in order to gather together experts with experience in treating chil dren undergoing CAPD in an attempt to exchange current information on the utilization of this emerging technique in children. Since pediatric pa tients comprise a small percentage of the CAPD population and since lim ited data were available concerning specific methodology and complica tions of CAPD in children, it was hoped that an international symposium would provide a forum for an exchange of experience that would ultimate ly lead to better adaptation and increased utilization of this technique.
List of contents
Cellular Abnormalities in Uremia.- A Comparison of Peritoneal Water and Solute Movement in Young and Older Children on CAPD.- Transperitoneal Movements of Solutes of Different Molecular Size in Children on CAPD.- CAPD in Children: Data from the European Dialysis and Transplant Association (EDTA) Registry.- Indications for CAPD and CCPD in Children.- Comparison of CAPD and CCPD in Children.- CAPD in Acute Renal Failure: Clinical Experience in Children.- Glucose Metabolism in Uremia: Effect of Hemodialysis and CAPD.- Lipoprotein Profiles in Plasma and Dialysate of Children on CAPD.- Protein Losses During Peritoneal Dialysis in Children.- Amino Acid Dialysis in Children on CAPD.- Dietary Survey in a Group of Children Treated with CAPD.- The Management of the Infant on CAPD.- Growth of the Patient on CAPD.- Thyrotropin-Releasing Hormone and Growth Hormone-Releasing Factor in the Evaluation of Hypophyseal Function in Children Undergoing CAPD.- Thyroid Function in Children on CAPD.- Somatostatin Secretion in Children on CAPD and CCPD.- Biochemical and Hormonal Abnormalities of Mineral Metabolism in Children on CAPD.- Aluminum-Containing Phosphate Binding Agents and Plasma Aluminum Levels in Children Undergoing CAPD: Preliminary Results with the Use of Calcium Carbonate.- Evolution of Renal Osteodystrophy and the Effect of High-Dose Calcitriol in Children Undergoing CAPD.- Renal Anemia in Children on CAPD.- Loss of Ultrafiltration and Peritoneal Membrane Alterations in Children on CAPD.- Sclerosing Peritonitis in Patients Treated by CAPD.- Five Years' Experience with CAPD/CCPD Catheters in Infants and Children.- Peritonitis in Children Undergoing CAPD Versus CCPD.- Pharmacokinetics of Various Antibiotics During CAPD.- Prevention and Treatment of Peritonitis in Children onCAPD.- The Importance of the CAPD Nurse in Dealing with Patient/Family Burnout.- Renal Transplantation in Children Treated by CAPD: A Report on a Cooperative Study.
About the author
RA Karl Schäfer, Limburg/Lahn, beschäftigt sich seit Jahren mit Familien- und Erbrecht.
